Prophylaxis of fungal infections

Mycoses, Supplement

Volumn 40, Issue 2, 1997, Pages 41-44

  Schuler, U S ^a,b   Haag, C ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Deep seated mycoses; Prophylaxis; Risk factors

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; NYSTATIN;

ASPERGILLUS; CANDIDIASIS; CONFERENCE PAPER; DISEASE TRANSMISSION; HUMAN; IMMUNE DEFICIENCY; MORBIDITY; MYCOSIS; PRIORITY JOURNAL; RISK FACTOR;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; CANDIDIASIS; FLUCONAZOLE; IMMUNOCOMPROMISED HOST; MYCOSES; RANDOMIZED CONTROLLED TRIALS;

EID: 0031441130     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Guiot, H. F, Fibbe, W. E. & van-'t-Wout, J. W. (1991) Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis Clin. Infect. Dis. 18, 525-532.
2. USPHS/IDSA prevention of opportunistic working group (1996) USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. Ann. Intern. Med. 124, 349-361.
3. Lumbreras, C., Cuervas-Mons, V., Jara, P, del Palacio, A., Turrión, V S, Barrios, C., Moreno, E., Noriega, A. R & Paya, C. V. (1996) Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J. Infect. Dis. 174, 583-588.
4. British Society for Antimicrobial Chemotherapy Working Party (1994) Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20, 522-528
5. Sherertz, R. J., Belani, A, Kramer, B. S., Elfenbein, G. J., Weiner, R. S., Sullivan, M L, Thomas, R G. & Samsa, G. P. (1987) Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients Am. J. Med. 83, 709-718.
6. Orth, B., Frei, R, Itin, P. H., Rinaldi, M. G, Speck, B, Gratwohl, A. & Widmer, A F. (1996) Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann. Intern Med. 125, 799-806.
7. Berger, C., Frei, R., Gratwohl, A., Tichelli, A., Hafliger, B. & Speck, B. (1988) A Candida krusei epidemic in a hematology department. Schweiz. Med Wochenschr. 118, 37-41.
8. Saxen, H., Virtanen, M., Carlson, P., Hoppu, K., Pohjavuori, M., Vaara, M., Vuopio-Varkila, J. & Peltola, H. (1995) Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr. Infect Dis J. 14, 776-781.
9. Pertowski, C. A., Baron, R. C, Lasker, B. A, Werner, S. B. & Jarvis, W. R. (1995) Nosocomial outbreak of Candida albicans sternal would infections following cardiac surgery traced to a scrub nurse. J. Infect. Dis. 172, 817-822.
10. Zunic, P., Lacotte, J, Pegoix, M., Buteux, G., Leroy, G., Mosquet, B. & Moulin, M. (1991) Saccharomyces boulardii fungemia. Apropos of a case. Therapie 46, 498-499.
11. Schmid, J., Tay, Y. P., Wan, L., Carr, M., Parr, D. & McKinney, W. (1995) Evidence for nosocomial transmission of Candida albicans obtained by Ca3 fingerprinting. J. Clin. Microbiol. 33, 1223-1230.
12. Reagan, D. R., Pfaller, M. A., Hollis, R. J. & Wenzel, R. P. (1995) Evidence of nosocomial spread of Candida albicans causing blood-stream infection in a neonatal intensive care unit Diagn. Microbiol. Infect. Dis. 21, 191-191.
13. Strausbaugh, L. J., Sewell, D. L., Ward, T. T, Pfaller, M. A, Heitzman, T. & Tjoelker, R. (1994) High frequency of yeast carriage on hands of hospital personnel. J. Clin. Microbiol. 32, 2299-2300.
14. Rangel-Frausto, M. S., Houston, A. K., Bale, M. J., Fu, C. & Wenzel, R. P. (1991) An experimental model for study of Candida survival and transmission in human volunteers Eur. J Clin. Microbiol. Infect. Dis. 13, 590-595.
15. Wiley, J. M., Smith, N., Leventhal, B. G., Graham, M. L, Strauss, L. C., Hurwitz, C. A, Modlin, J, Mellits, D., Baumgardner, R., Corden B. J. et al (1990) Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J. Clin. Oncol. 8, 280-286.
16. Martino, P., Girmenia, C., Venditti, M., Micozzi, A., Santilli, S., Burgio, V. L. & Mandelli, F. (1989) Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 64, 2030-2034.
17. Martino, P., Girmenia, C., Micozzi, A., De-Bernardis, F., Boccanera, M. & Cassone, A. (1991) Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis. 13, 797-804.
18. Pittet, D., Monod, M., Suter, P. M., Frenk, E. & Auckenthaler, R. (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann. Surg 220, 751-758.
19. Reagan, D. R, Pfaller, M. A., Hollis, R. J. & Wenzel, R. P. (1990) Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J. Clin. Microbiol. 28, 2733-2738.
20. van-Belkum, A., Melchers, W. J., de-Pauw, B. E., Scherer, S., Quint, W. & Meis, J F. (1994) Genotypic characterization of sequential Candida albicans isolates from fluconazole-treated neutropenic patients. J. Infect. Dis 169, 1062-1070.
21. Pfaller, M., Cabezudo, I., Koontz, F., Bale, M. & Gingrich, R. (1987) Predictive value of surveillance cultures for systemic infection due to Candida species. Eur J. Clin. Microbiol. 6, 628-633.
22. Kataoka, S., Kashiwa, M., Saku, K., Handa, N. & Akiyama, H. (1995) Candidemia in non-neutropenic patients with an intravenous hyperalimentation catheter: good prognosis of Candida parapsilosis infection. Kansenshogaku Zasshi 69, 969-974.
23. Blaschke-Hellmessen, R., Kreuz, M. & Sprung, M. (1985) Umweltresistenz und naturliche Keimreservoire medizinisch bedeutsamer Sproßpilze. Z. gesamte Hyg 31, 712-715.
24. Bow, E. J., Loewen, R., Cheang, M S. & Schacter, B (1995) Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin. Infect. Dis. 21, 361-369.
25. Goodman, J. L., Winston, D. J, Greenfield, R. A, Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J. et al, (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 326, 845-851.
26. Slavin, M. A, Osborne, B., Adams, R., Levenstein, M. J, Schoch, H. G., Feldman, A. R., Meyers, J. D. & Bowden, R. A (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J. Infect. Dis. 171, 1545-1552.
27. Zimmermann, T., Yeates, R. A., Albrecht, M, Laufen, H. & Wildfeuer, A. (1994) Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects. Int. J. Clin Pharmacol. Res 14, 87-93.
28. Vreugdenhil, G., VanDijke, B J, Donelly, J P, Novakova, J. R., Raemaekers, J. M, Hoogkamp-Korstanje, M. A., Koster, M. & de-Pauw, B. E. (1991) Efficacy of itraconazole in the prevention of fungal infection among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study Leuk. Lymphoma 11, 353-358.
29. Behre, G. F. Schwartz, S., Lenz, K., Ludwig, W. D., Wandt, H., Schilling, E., Heinemann, V., Link, H., Trittin, A., Boenisch, O, Treder, W., Siegert, W., Hiddemann, W. & Beyer, J. (1995) Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients. Ann Hematol. 71, 287-291.
30. Dubois, J., Bartter, T., Gryn, J. & Pratter, M. R. (1995) The physiologic effects of inhaled amphotericin B. Chest 108, 750-753.
31. O'Donnell, M. R., Schmidt, G. M., Tegtmeier, B. R., Faucett, C., Fahey, J L, Ito, J., Nademanee, A., Niland, J., Parker, P., Smith, E. P. et al. (1994) Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J. Clin. Oncol 12, 827-834.
32. Poynton, C. H., Jackson, S., Fegan, C., Barnes, R. A. & Whittaker, J. A. (1992) Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplant. 9, 451-457.
33. Sullivan, K. M., Kopecky, K. J, Jocom, J., Fisher, L, Buchner, C. D, Meyers, J. D., Counts, G. W., Bowden, R. A, Peterson, F. B, Witherspoon, R. P. et al. (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N. Engl. J. Med. 323, 705-712.
34. Winston, D. J., Ho, W. G., Bartoni, K. & Champlin, R. E. (1993) Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients. Bone Marrow Transplant. 12, 283-288.
35. Klaesson, S, Ringden, O., Ljungman, P., Aschan, J., Hägglund, H. & Winiarski, J. (1995) Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver? Transplantation 60, 1225-1230.
36. Lupinetti, F. M., Behrendt, D. M., Giller, R. H., Trigg, M. E & de-Alarcon, P. (1992) Pulmonary resection for fungal infection in children undergoing bone marrow transplantation. J. Thorac Cardiovasc. Surg. 104, 684-687.
37. Richard, C, Romón, I., Baro, J, Insunza, A., Loyola, I., Zurbano, F., Tapia, M, Iriondo, A, Conde, E. & Zubizarreta, A. (1993) Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant. 12, 237-241.
38. Karp, J. E, Burch, P. A. & Merz, W. G. (1988) An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am. J. Med. 85, 203-206.